| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/17/2013 | CN103052637A 醛糖还原酶抑制剂及其用途 Aldose reductase inhibitors and their use |
| 04/17/2013 | CN103044951A Asymmetric synthetic method and application of double para-position donator and receptor type porphyrin molecules |
| 04/17/2013 | CN103044435A Novel coordination polymer nano-material and preparation method thereof |
| 04/17/2013 | CN103044434A Preparation method for chiral pentabasic bicyclic guanidine based on aziridine |
| 04/17/2013 | CN103044433A ANTIVIR sodium salt dihydrate crystal and preparation method of ANTIVIR sodium salt dihydrate crystal |
| 04/17/2013 | CN103044432A 双环杂芳基化合物 Bicyclic heteroaryl compounds |
| 04/17/2013 | CN103044431A Novel preparation method of penoxsulam |
| 04/17/2013 | CN103044430A Pyrrolodione-thiophene quinone compound, and preparation method and application thereof |
| 04/17/2013 | CN103040834A Pemetrexed disodium for injection and preparation method thereof |
| 04/17/2013 | CN102276803B Polymeric material containing anthracene and pyrrole-pyrrole-dione unit, preparation method thereof and application thereof |
| 04/17/2013 | CN102180883B Substituted porphyrin gold (III) compounds with anticancer activity and preparation method thereof |
| 04/17/2013 | CN102167701B Fluorine-containing diphenyl-pyrrolo-pyrrolidinedione (DPP) pigments and preparation method thereof |
| 04/17/2013 | CN102127084B Alkoxy bicyclic guanidine as well as preparation method and application thereof |
| 04/17/2013 | CN102127083B Alkane group bicyclo-guanidine, preparation method and application of alkane group bicyclo-guanidine |
| 04/17/2013 | CN102127082B Hydroxyl hydrocarbyl bicyclic guanidine and preparation method and use thereof |
| 04/17/2013 | CN101952283B Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 04/17/2013 | CN101918406B Compounds for the treatment of hepatitis c |
| 04/17/2013 | CN101899048B Salt of (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- carboxylic acid methyl ester |
| 04/17/2013 | CN101679437B Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 04/17/2013 | CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/17/2013 | CN101501036B Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 04/17/2013 | CN101006092B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatment agent using the same |
| 04/16/2013 | US8420810 Bicyclic heterocyclic compound |
| 04/16/2013 | US8420805 Process for preparing prophyrin derivatives, such as protoprophyrin (IX) and synthesis intermediates |
| 04/16/2013 | US8420804 Formyl- and acetal-porphyrins bearing tripodal linking groups |
| 04/16/2013 | US8420689 Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/16/2013 | US8420657 Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors |
| 04/16/2013 | US8420633 Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420629 Azetidine and cyclobutane derivatives as JAK inhibitors |
| 04/16/2013 | US8420626 Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof |
| 04/16/2013 | CA2568836C Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 04/16/2013 | CA2486157C Opioid and opioid-like compounds and uses thereof |
| 04/11/2013 | WO2013052699A2 Novel quinoxaline inhibitors of pi3k |
| 04/11/2013 | WO2013052162A1 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| 04/11/2013 | WO2013051672A1 Medicinal agent comprising thiazolidine derivative or salt thereof as active ingredient |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013050987A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | WO2013050448A1 4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS |
| 04/11/2013 | WO2013050446A1 SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS |
| 04/11/2013 | WO2013050437A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals |
| 04/11/2013 | WO2013050434A1 Heterocyclylpyri(mi)dinylpyrazole |
| 04/11/2013 | WO2013050424A1 NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF |
| 04/11/2013 | WO2013050310A1 Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine |
| 04/11/2013 | WO2013015535A3 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient |
| 04/11/2013 | WO2013009140A3 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 04/11/2013 | WO2012158843A3 Kinase inhibitors |
| 04/11/2013 | US20130090470 Optically-detectable enzyme substrates and their method of use |
| 04/11/2013 | US20130090340 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 04/11/2013 | US20130090336 N-containing heterocyclic compounds |
| 04/11/2013 | US20130090331 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 04/11/2013 | US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/11/2013 | CA2851405A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | CA2851187A1 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| 04/11/2013 | CA2851142A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals |
| 04/11/2013 | CA2850763A1 Novel quinoxaline inhibitors of pi3k |
| 04/11/2013 | CA2849751A1 Novel chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor mediated disorders and chiral synthesis thereof |
| 04/11/2013 | CA2847092A1 Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine |
| 04/10/2013 | EP2578588A1 Novel 1,4-diazepam pde-5 inhibitor derivatives |
| 04/10/2013 | EP2578586A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF |
| 04/10/2013 | EP2578583A1 Fused heterocyclic derivatives and methods of use |
| 04/10/2013 | EP2576564A2 Macrocyclic hepatitis c serine protease inhibitors |
| 04/10/2013 | EP2576563A1 A NOVEL SYNTHETIC APPROACH TO ß-AMINOBUTYRYL SUBSTITUTED COMPOUNDS |
| 04/10/2013 | EP2576562A1 Processes for the preparation of dipyridamole |
| 04/10/2013 | EP2576561A1 Heterocyclic compounds as janus kinase inhibitors |
| 04/10/2013 | EP2576560A1 Substituted imidazopyrazines |
| 04/10/2013 | EP2576559A1 Inhibitors of jnk |
| 04/10/2013 | EP2576558A1 Process for the preparation of 5-substituted-8-alkoxy[1,2,4]triazolo[1,5-c]pyrimidin-2-amines |
| 04/10/2013 | EP2576557A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES |
| 04/10/2013 | EP2576550A1 Organic compounds |
| 04/10/2013 | EP2576549A2 Bicyclic heteroaryl kinase inhibitors and methods of use |
| 04/10/2013 | EP2576537A1 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 04/10/2013 | EP2575817A1 Organic compounds |
| 04/10/2013 | CN103038236A A novel synthetic approach to beta-aminobutyryl substituted compounds |
| 04/10/2013 | CN103038235A Substituted imidazopyrazines |
| 04/10/2013 | CN103038234A Compounds with antibacterial activity against clostridium |
| 04/10/2013 | CN103038233A Pyridone and aza-pyridone compounds and methods of use |
| 04/10/2013 | CN103030645A Method for preparing high-purity heme on large scale and application of heme |
| 04/10/2013 | CN103030644A Preparation method for Talaporfin and intermediate thereof |
| 04/10/2013 | CN103030643A Six-ring indole alkaloid and preparation method thereof |
| 04/10/2013 | CN103030642A Preparation method of pemetrexed or pemetrexed salt |
| 04/10/2013 | CN103030641A Preparation method of pemetrexed disodium key intermediate |
| 04/10/2013 | CN103030640A Preparation method of pemetrexed or pemetrexed salt |
| 04/10/2013 | CN103030634A Bicyclo-containing oxazolidinone antibiotics |
| 04/10/2013 | CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device |
| 04/10/2013 | CN102159578B Salts of tetrahydroimidazo [1,5-a] pyrazine derivatives, preparation methods and pharmaceutical use thereof |
| 04/10/2013 | CN101686981B Diazo bicyclic smac mimetics and the uses thereof |
| 04/10/2013 | CN101684118B Use of tricyclic compounds as glycine transport inhibitors |
| 04/10/2013 | CN101195599B 2,4,6-phenyl substituted cyclic ketoenols |
| 04/09/2013 | US8415486 IAP inhibitors |
| 04/09/2013 | US8415484 Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 04/09/2013 | US8415386 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| 04/09/2013 | US8415362 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 04/09/2013 | US8415355 Pyrrolopyrimidine compounds and their uses |
| 04/09/2013 | US8415347 Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 04/09/2013 | US8415336 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 04/09/2013 | US8415297 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/09/2013 | CA2704986C Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye |
| 04/09/2013 | CA2531050C Pharmaceutical compounds |
| 04/04/2013 | WO2013049174A1 Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers |